Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
Clinical Trials Arena on MSN
Gilead’s HIV single-pill combo meets primary endpoints in pivotal trial
Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...
South Africa takes the lead in HIV prevention with a groundbreaking twice-a-year injection being added to the Essential Medicines List.
A memo regarding HIV treatment and prevention, issued by the State Department on February 6, offers a stark illustration of the impact of the Trump administration on global health. One section of the ...
KUALA LUMPUR (Thomson Reuters Foundation) - The Philippines has kicked off a pilot project offering anti-HIV drugs to gays and transgender women as new infection rates in the country buck global ...
Canonsburg, Pa.-based Mylan argues the U.S. is wasting billions of dollars on name brand anti-HIV drugs, instead of making generic alternatives, according to Science. At the International AIDS ...
Eswatini on Tuesday became the first African country to receive lenacapavir, the first twice-yearly HIV prevention injection hailed by global health officials as a game-changer in the fight against a ...
As a result of the new administration's actions, health centers funded by PEPFAR, the U.S. President's Emergency Plan for AIDS Relief, are closing... Engage Men's Health, a nonprofit organization in ...
A big HIV/AIDS conference takes place next week in Munich, Germany. AIDS 2024, the 25th International AIDS Conference, will attract attendees from around the world. Ahead of the event taking place, ...
Engage Men's Health, a nonprofit organization in South Africa, offers testing and medications to prevent and manage HIV at three clinics throughout the country — all for free. That is, they did until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results